Exercise News and Research

Latest Exercise News and Research

Multicomponent training improves strength, power and muscle mass in people over 90

After doing specific training for 12 weeks, people over the age of 90 improved their strength, power and muscle mass. This was reflected in an increase in their walking speed, a greater capacity to get out of their chairs, an improvement in their balance, a significant reduction in the incidence of falls and a significant improvement in muscle power and mass in the lower limbs.

27 Sep 2013

PneumRx performs over 1500 RePneu LVRC treatments for patients with severe emphysema

PneumRx, Inc., a leader in interventional pulmonology, announced that over 1500 procedures have been performed using the RePneu Lung Volume Reduction Coil System for patients with severe emphysema.

26 Sep 2013

Wayne State aims to develop advanced education program for radiation oncology

The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.

26 Sep 2013

Spanish scientists discover melatonin consumption helps control weight gain

Melatonin is a natural hormone segregated by the body and melatonin levels generally increase in the dark at night. It is also found in fruit and vegetables like mustard, Goji berries, almonds, sunflower seeds, cardamom, fennel, coriander and cherries.

26 Sep 2013

New research leads to better understanding of what happens during heart failure

New research from Western University (London, Canada) is leading to a better understanding of what happens during heart failure; knowledge that could lead to better therapeutics or a more accurate predictor of risk.

25 Sep 2013

Stem cell lines are ideal research tools for designing models to understand disease progression

Scientists from King's College London have announced that 16 human embryonic stem (hES) cell lines have been approved by the US National Institutes of Health (NIH) and placed on their Stem Cell Registry, making them freely available for federally-funded research in the USA.

25 Sep 2013

Engineered nanomaterials inhalation negatively impacts gestational development in animal models

After a decade of rapidly growing industrial use, unimaginably tiny particles surround us everywhere, every day, in everything we do. Used in the manufacturing of cosmetics, clothing, paints, food, drug delivery systems and many other familiar products we all use daily, little is known about the effects these materials have on health.

25 Sep 2013

Appropriate exercise programs can provide benefits to people with asthma

Appropriate exercise programs can provide valuable benefits to people with asthma, helping to reduce the severity of attacks or prevent them entirely, finds a new evidence review in The Cochrane Library.

25 Sep 2013

Exercise and diet led to less knee pain for adults with knee osteoarthritis

Among overweight and obese adults with knee osteoarthritis, combining intensive diet and exercise led to less knee pain and better function after 18 months than diet-alone and exercise-alone, according to a study in the September 25 issue of JAMA.

25 Sep 2013

Breastfeeding and personality: an interview with Dr Amy Brown

In the UK we've got quite a problem with breastfeeding. The government recommends that all women should breastfeed for six months, exclusively just breast milk, and then for up to a year and beyond. But quite a few women struggle in the UK. About 80% initiate breastfeeding but that drops off really quickly.

24 Sep 2013

Rhythm starts RM-493 clinical trials in obesity patients with genetic deficiency

Rhythm announced today the initiation of the first of a series of clinical trials with RM-493, the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of obesity in individuals with a genetic deficiency in the MC4R pathway.

24 Sep 2013

Changes in national diets linked to dramatic rise in AD prevalence in Japan and developing countries

In a paper just published electronically in the Journal of Alzheimer's Disease, dramatic increases in Alzheimer's disease in Japan and significant increases in developing countries are linked to changes in national diets.

24 Sep 2013

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.

24 Sep 2013

Parent sleep education improves daytime behavior of children with ASD

Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.

24 Sep 2013

FDA's final guidance outlines tailored approach to mobile medical apps

Today, the U.S. Food and Drug Administration issued final guidance for developers of mobile medical applications, or apps, which are software programs that run on mobile communication devices and perform the same functions as traditional medical devices. The guidance outlines the FDA's tailored approach to mobile apps.

24 Sep 2013

Respicardia reports results from remede System Pilot Study for central sleep apnea treatment

Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.

24 Sep 2013

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

23 Sep 2013

Abbvie, Ablynx Ink Up To $840M RA, SLE Collaboration

...

23 Sep 2013

HP launches new CDC-recognized Diabetes Prevention Program for Bronx residents

Health People (HP) announced today the launch of its new Centers for Disease Control and Prevention (CDC)-recognized Diabetes Prevention Program for Bronx residents to help the borough combat its high diabetes-related death rate - the highest in the city.

23 Sep 2013

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

Ablynx and AbbVie today announced that they have entered into a global license agreement to develop and commercialize the anti-IL-6R Nanobody, ALX-0061, to treat inflammatory diseases.

23 Sep 2013

Exercise News and Research

Latest Exercise News and Research

Multicomponent training improves strength, power and muscle mass in people over 90

PneumRx performs over 1500 RePneu LVRC treatments for patients with severe emphysema

Wayne State aims to develop advanced education program for radiation oncology

Spanish scientists discover melatonin consumption helps control weight gain

New research leads to better understanding of what happens during heart failure

Stem cell lines are ideal research tools for designing models to understand disease progression

Engineered nanomaterials inhalation negatively impacts gestational development in animal models

Appropriate exercise programs can provide benefits to people with asthma

Exercise and diet led to less knee pain for adults with knee osteoarthritis

Breastfeeding and personality: an interview with Dr Amy Brown

Rhythm starts RM-493 clinical trials in obesity patients with genetic deficiency

Changes in national diets linked to dramatic rise in AD prevalence in Japan and developing countries

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Parent sleep education improves daytime behavior of children with ASD

FDA's final guidance outlines tailored approach to mobile medical apps

Respicardia reports results from remede System Pilot Study for central sleep apnea treatment

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Abbvie, Ablynx Ink Up To $840M RA, SLE Collaboration

HP launches new CDC-recognized Diabetes Prevention Program for Bronx residents

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Exercise News and Research

Latest Exercise News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in